In This Article:
As February 2025 unfolds, the U.S. stock market is experiencing a notable downturn, with major indices like the S&P 500 and Nasdaq Composite extending their slump amid significant declines in technology shares. In this climate of uncertainty, investors may find opportunities in stocks that are potentially undervalued, offering a chance to buy at a discount as market volatility continues to shape investment decisions.
Top 10 Undervalued Stocks Based On Cash Flows In The United States
Name | Current Price | Fair Value (Est) | Discount (Est) |
SouthState (NYSE:SSB) | $98.74 | $193.86 | 49.1% |
Brookline Bancorp (NasdaqGS:BRKL) | $11.58 | $22.29 | 48% |
Northwest Bancshares (NasdaqGS:NWBI) | $12.42 | $24.55 | 49.4% |
Old National Bancorp (NasdaqGS:ONB) | $23.27 | $45.45 | 48.8% |
Cadre Holdings (NYSE:CDRE) | $33.35 | $64.79 | 48.5% |
Similarweb (NYSE:SMWB) | $9.45 | $18.06 | 47.7% |
Advanced Micro Devices (NasdaqGS:AMD) | $108.11 | $214.13 | 49.5% |
Fluence Energy (NasdaqGS:FLNC) | $6.59 | $12.84 | 48.7% |
Verra Mobility (NasdaqCM:VRRM) | $25.84 | $49.08 | 47.4% |
Nutanix (NasdaqGS:NTNX) | $68.43 | $133.03 | 48.6% |
Let's explore several standout options from the results in the screener.
Bridge Investment Group Holdings
Overview: Bridge Investment Group Holdings Inc is a publicly owned real estate investment manager with a market cap of approximately $959 million.
Operations: Bridge Investment Group Holdings Inc generates revenue primarily as a fully integrated real estate investment manager, with this segment contributing $404.93 million.
Estimated Discount To Fair Value: 10.8%
Bridge Investment Group Holdings is currently trading slightly below its estimated fair value of US$11.89, with a share price around US$10.6, suggesting potential undervaluation based on cash flows. The company recently became profitable and reported significant earnings growth, with forecasts indicating continued strong profit expansion at 51.4% annually over the next three years. However, it has a high level of debt and experienced significant insider selling recently. Apollo Global Management's acquisition could impact future public trading status as Bridge transitions to private ownership later this year.
Haemonetics
Overview: Haemonetics Corporation is a healthcare company that offers a range of medical products and solutions both in the United States and internationally, with a market cap of approximately $3.17 billion.